Investment
Features
FeesSafety
Academy
More
Pluang+

Paramount Skydance to settle antitrust lawsuit, advancing $110B merger with Warner Bros. Discovery

Market News
21 Sep 2026
CNBC
View Source
Bullish
Paramount Skydance to settle antitrust lawsuit, advancing $110B merger with Warner Bros. Discovery

Paramount Skydance will settle with state attorneys general who sued to block its $110 billion merger with Warner Bros. Discovery, allowing the deal to proceed. The lawsuit, led by California and 11 other states, raised antitrust concerns and threatened to delay the merger until mid-2027, costing Paramount hundreds of millions in fees. The merger combines major film studios, TV networks, and streaming services Paramount+ and HBO Max. With the settlement, the deal is expected to close without further delay, benefiting both companies and their investors.

The Paramount and Warner Bros. merger is set to proceed after settling with state attorneys general. For readers following the media sector, here is Pluang's market snapshot as of Sep 21, 2026 22:02 WIB: 29 of 42 priced US media stocks rose today. Manchester United PLC (MANU) rose 3.20% to USD 20.32, Tencent Music Entertainment Group (TME) increased 2.96% to USD 7.99, and Zillow Group Inc Class A (ZG) gained 2.66% to USD 31.05.

More News

FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...

Market News
Bullish
1 hour ago
DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global Inc. will announce its financial results for the third quarter ending September 30, 2026, on October 27 after the stock market closes. The company will hold a conference call and webcast to discuss the results, providing investors with ins...

Company Fundamentals
Neutral
1 hour ago
Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics has appointed John O’Malley, M.D., Ph.D., as its Chief Medical Officer. Dr. O’Malley brings extensive experience in immunology and clinical development from his previous roles at CRISPR Therapeutics and Sanofi. His leadership ...

Market News
Bullish
1 hour ago
Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware introduced its Model Context Protocol (MCP) Server Protection solution to help organizations secure the integration layer where AI agents connect to enterprise applications and workflows. This new security tool provides visibility into MCP in...

Market News
Bullish
2 hours ago
Global anthracite market to reach $16.8B by 2035, driven by steel and water filtration demand.

Global anthracite market to reach $16.8B by 2035, driven by steel and water filtration demand.

The global anthracite market, valued at $11.9 billion in 2025, is projected to grow to $16.8 billion by 2035 with a 3.5% CAGR. Growth is fueled by rising demand in steel production, water filtration, and advanced industrial uses due to anthracite's h...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App